Long-Term Safety of Risankizumab in Patients with Psoriatic Disease: A Comprehensive Analysis from Clinical Trials

Abstract Introduction Risankizumab has demonstrated a favourable safety profile in patients with psoriatic disease (moderate-to-severe psoriasis [PsO] and psoriatic arthritis [PsA]). We evaluated the long-term safety of risankizumab in psoriatic disease. Methods Long-term safety was evaluated by ana...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
Main Authors: Kenneth B. Gordon (Author), Andrew Blauvelt (Author), Hervé Bachelez (Author), Laura C. Coates (Author), Filip E. Van den Bosch (Author), Blair Kaplan (Author), Willem Koetse (Author), Doug G. Ashley (Author), Ralph Lippe (Author), Ranjeeta Sinvhal (Author), Kim A. Papp (Author)
Format: Knjiga
Izdano: Adis, Springer Healthcare, 2024-08-01T00:00:00Z.
Teme:
Online dostop:Connect to this object online.
Oznake: Označite
Brez oznak, prvi označite!

Internet

Connect to this object online.

3rd Floor Main Library

Podrobnosti zaloge 3rd Floor Main Library
Signatura: A1234.567
Kopija 1 Prosto